Literature DB >> 10698178

Differences in gonadotropin-releasing hormone-induced calcium signaling between melatonin-sensitive and melatonin-insensitive neonatal rat gonadotrophs.

H Zemková1, J Vanecek.   

Abstract

The sensitivity of GnRH-stimulated calcium signaling to melatonin, in a subpopulation of neonatal gonadotrophs, is supposed to be attributable to melatonin receptors. However, it is not yet known whether the intracellular pathway for GnRH action in melatonin-sensitive cells is the same as in melatonin-insensitive cells. By monitoring intracellular Ca2+ changes as an outward current carried through apamin-sensitive Ca2+-activated K+ channels, we compared GnRH-induced calcium responses in these two subpopulations of neonatal gonadotrophs. GnRH induced various oscillatory, as well as nonoscillatory, responses in both cell types that was not related to melatonin sensitivity. Melatonin-sensitive GnRH-induced responses could be clearly distinguished according to the pharmacological properties of their latency. The latency increased in zero extracellular Ca2+ or with the addition of nifedipine, staurosporine, and ryanodine. This effect was only rarely observed in melatonin-insensitive cells. This indicates that there are two pathways for initiation of GnRH-induced calcium signaling in neonatal gonadotrophs. The first pathway is mediated by inositol 1,4,5,-trisphosphate production, whereas the second involves extracellular calcium entry through voltage-dependent L-type Ca2+ channels, protein kinase C activation, and Ca2+ release from a ryanodine-sensitive store, which may coactivate Ca2+ release from an inositol 1,4,5,-trisphosphate-sensitive store. Only the second mechanism is accessible to inhibition by melatonin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698178     DOI: 10.1210/endo.141.3.7351

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Role of melatonin on diabetes-related metabolic disorders.

Authors:  Javier Espino; José A Pariente; Ana B Rodríguez
Journal:  World J Diabetes       Date:  2011-06-15

Review 3.  Neurotransmitter receptors as signaling platforms in anterior pituitary cells.

Authors:  Hana Zemková; Stanko S Stojilkovic
Journal:  Mol Cell Endocrinol       Date:  2017-07-03       Impact factor: 4.102

4.  Cardioprotective effects of melatonin on recovery of rat donor hearts after 12-hour preservation.

Authors:  Sihai Gao; Ping Li; Tiecheng Pan; Chenyuan Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

Review 5.  Ion Channels of Pituitary Gonadotrophs and Their Roles in Signaling and Secretion.

Authors:  Stanko S Stojilkovic; Ivana Bjelobaba; Hana Zemkova
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-09       Impact factor: 5.555

Review 6.  Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon.

Authors:  Elmar Peschke; Ina Bähr; Eckhard Mühlbauer
Journal:  Int J Mol Sci       Date:  2013-03-27       Impact factor: 5.923

7.  Voltage-dependent Ca2+ channels, not ryanodine receptors, activate Ca2+-dependent BK potassium channels in human retinal pigment epithelial cells.

Authors:  Sönke Wimmers; Claire Halsband; Sebastian Seyler; Vladimir Milenkovic; Olaf Strauss
Journal:  Mol Vis       Date:  2008-12-15       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.